Question Bank › Better business coming in than going out

Better business coming in than going out

Better business coming in than going out: management describes the quality of new intake visibly exceeding what it is re

Calls Tested
483
Answered YES
22
Hit Rate
4.6%
rare by design

CTO Realty Growth, Inc. (CTO) — this company's answers

NO on the Q2 2023 call 2023-07-28 B
The model's full reasoning — Q2 2023 call → NO我们只需要根据文本判断是否满足条件。管理层的表述中,关于新收购的资产(如Plaza at Rockwall)有低于市场租金的提升机会,但这是关于投资组合的,不是关于“正在接收的业务”与“正在结束的业务”的对比。关于租赁活动,提到可比租金增长25%,但这是市场租金上涨还是新租约质量?没有明确对比新旧租约的经济性。关于The Hall的更换,新运营商租金可能不是完全替代,但风险调整后更好,但这是关于一个特定物业的租户更换,不是整体业务质量对比。没有明确说新业务比旧业务更好且旧业务正在滚出。因此答案应为NO。

← Back to the full CTO analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that the business the company is TAKING IN RIGHT NOW is of visibly HIGHER QUALITY than the business it is finishing, replacing, or letting run off — that is, does management contrast the character of its NEW incoming work, orders, contracts, customers, products, or engagements against the OLDER business still sitting in its reported results, and indicate that as the old naturally rolls off and the new becomes a bigger share, the company's results will improve on the strength of business ALREADY being taken in today? Answer YES when management's own words convey, in whatever form fits the industry, ONE coherent phenomenon with both halves present as a present-tense reality: (1) AN IN-VERSUS-OUT QUALITY CONTRAST, STATED BY MANAGEMENT. Management describes the business currently entering the company as better than what it is replacing — better priced, better margined, better terms, longer duration, more valuable work, stronger or higher-quality customers, a richer product or service mix, or otherwise economically superior — and makes the comparison against the company's OWN existing or outgoing book, not against competitors or the market. The forms vary widely: new orders or bookings coming in at better economics than the work being completed; new contracts, policies, leases, loans, or engagements written on better terms than those expiring; the sales mix of what is being sold now visibly richer than the mix still dominating reported results; lower-quality, lower-margin, or problematic business being deliberately allowed to run off while better business fills its place; or management explaining that what is in the backlog, book, or pipeline of committed work today carries better economics than what is currently being recognized. (2) THE TURNOVER IS REAL, CURRENT, AND ALREADY IN THE NUMBERS' FUTURE. The higher-quality intake must be described as actually being received, signed, booked, or written NOW — real transactions already happening, not aspirations to move upmarket or plans to improve mix — and management should convey, directly or plainly in substance, that reported results still largely reflect the older, lower-quality business, so the improvement arrives as the mix naturally turns over, without depending on new demand, market recovery, or events not yet secured. Answer NO if management discusses only overall demand strength, volume growth, or a good quarter without contrasting the quality of incoming business against outgoing. NO if the improvement in economics comes chiefly from raising prices to pass through costs, or from market prices moving favorably, rather than from a genuine change in the character of the business being taken in. NO if the better mix is only targeted, planned, or hoped for rather than already arriving. NO if the contrast is purely between a good quarter and a bad quarter, or between this company and competitors, rather than between the company's own incoming and outgoing business. NO if the new business's superiority is asserted only generically ("higher quality growth", "improving mix") with nothing concrete about what makes the incoming business better. NO if the reported results already fully reflect the better mix, with no meaningful turnover still ahead. NO if the idea appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
ASB Associated Banc-Corp Q1 2024 2024-04-25 A
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
ALL The Allstate Corporation Q3 2023 2023-11-02 C+
SPT Sprout Social, Inc. Q2 2023 2023-08-04 B+
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
OEC Orion Engineered Carbons S.A. Q4 2022 2023-02-17 B+
BBD Banco Bradesco S.A. Q3 2022 2022-11-09 D
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
KTB Kontoor Brands, Inc. Q3 2021 2021-11-04 A
CYBR CyberArk Software Ltd. Q3 2021 2021-11-04 B+
EHTH eHealth, Inc. Q2 2021 2021-07-29 F
ADSK Autodesk, Inc. Q3 2019 2018-11-20 A
GECC Great Elm Capital Corporation Q3 2018 2018-11-13 B
CUBI Customers Bancorp, Inc. Q3 2018 2018-10-26 C+
T AT&T Inc. Q3 2018 2018-10-24 C+
ESS Essex Property Trust, Inc. Q2 2018 2018-08-03 B+
MKC McCormick & Company, Incorporated Q2 2018 2018-06-28 C+
ALLY Ally Financial Inc. Q1 2018 2018-04-26 B+
ATI Allegheny Technologies Incorporated Q1 2018 2018-04-24 B
HSTM HealthStream, Inc. Q3 2017 2017-10-24 C
MTG MGIC Investment Corporation Q3 2017 2017-10-18 B+
BLKB Blackbaud, Inc. Q1 2017 2017-05-02 B+

How the model reasoned

HSTM · Q3 2017 → YESThe question is about whether management conveys that the business they're taking in right now is of visibly higher quality than the business they're finishing or letting run off. YES The transcript shows management explicitly contrasting incoming business against outgoing: - Patient Experience: "Existing clients also continue to convert from a phone modality to email and SMS text surveying modality... This conversion trend to continue... expected to have a positive impact... on patient experience margins." (lower price, higher margin shift already happening) - Provider Solutions: "the move from installed software sales to software as service sales... challenge revenue growth... but not profitability growth" and "backlog of unimplemented customers... significantly reduced" - Laerdal/HeartCode: "the new product we believe is right now based on contracts.
GFS · Q3 2021 → YESThe question is about whether management conveys that the business they're taking in right now is of visibly higher quality than the business they're finishing or letting run off. YES The transcript shows management explicitly contrasting the incoming business with the outgoing: compute revenue is declining "as expected" due to customers shifting to smaller nodes, while "newer high-margin customer designs" are ramping in 2H 2022 to offset it. They tie this directly to mix improvement from "d differentiated solutions become a larger portion" and "feature-rich" platforms (FDX, RF SOI, silicon photonics) growing while feature-rich CMOS is flat or down. LTAs signed now carry "pricing improvements" baked in for 2022+, with new agreements committing future capacity at those better terms.
CYBR · Q3 2021 → YESThe question is about whether management conveys that the new business they're taking in is of higher quality than the old business they're replacing, and that as the old rolls off, results will impro...YES Management explicitly contrasts the incoming subscription business (new logos, SaaS bookings, Privileged Cloud, EPM) as higher-quality than the outgoing perpetual license business it is replacing. They describe it as delivering “faster type of value,” “higher lifetime value over time,” and “more users and more products faster ,” while noting that the current revenue and profitability headwind from the mix shift is “obscuring the P&L” and that results will improve once the transition completes.

More from the question bank

Doing more and earning better on each oneFrom explaining to teachingBought-and-paid-for optionalityExit rate above the printCheck it yourselvesCompounding order flowAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.